Press release
Ibogaine By David DardashtiI Collaborates on Groundbreaking Research Project with Doctor Leslie Mitchelson
The collaboration brings together the extensive experience of David Dardashti in ibogaine therapy and Dr. Mitchelson's expertise in anti-aging research. By analyzing data from past patients, the team seeks to identify specific patterns and biomarkers related to age that could influence the effectiveness of ibogaine treatment.
"We are thrilled to partner with Dr. Mitchelson on this important research initiative," said David Dardashti. "Ibogaine has shown tremendous promise in addressing addiction, trauma, and other mental health conditions. By isolating the age component, we can potentially optimize dosing and enhance the therapeutic benefits of ibogaine for individuals of different age groups."
Dr. Mitchelson added, "Ibogaine's unique ability to promote neuroplasticity and cellular regeneration has intriguing implications for anti-aging research. This collaboration provides a valuable opportunity to explore the potential of ibogaine in mitigating the effects of aging and improving overall well-being."
The research project will involve a thorough examination of patient records, including medical histories and treatment outcomes. This data will be analyzed to identify trends and patterns that may inform the development of standardized protocols for age-specific dosing of ibogaine.
The goal of this research is to improve the safety and efficacy of ibogaine therapy by tailoring dosing regimens to the specific needs of patients based on their age. By establishing age-specific dosing guidelines, healthcare providers can better ensure that patients receive the appropriate amount of ibogaine for their individual circumstances, reducing the risk of adverse reactions and optimizing treatment outcomes.
The implications of this research could be significant for the future of ibogaine therapy and personalized medicine. By developing standardized protocols for age-specific dosing, healthcare providers can enhance the precision and effectiveness of ibogaine treatment, potentially leading to improved patient outcomes and a more personalized approach to care. This research has the potential to revolutionize the field of ibogaine therapy and pave the way for a new era of personalized medicine
About Ibogaine by David Dardashti:
Ibogaine by David Dardashti is a leading provider of ibogaine treatment, offering a safe and supportive environment for individuals seeking to overcome addiction and trauma. With a commitment to personalized care and holistic healing, Ibogaine by David Dardashti has helped countless individuals transform their lives.
About Dr. Leslie Mitchelson:
Dr. Leslie Mitchelson is a highly respected biomedical engineer with extensive experience in anti-aging research and treatment. With a passion for innovation and a dedication to improving human health, Dr. Mitchelson has made significant contributions to the field of regenerative medicine.
Media Contact
Company Name: Ibogaine By David Dardashti
Contact Person: Cole Barressi
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ibogaine-by-david-dardashtii-collaborates-on-groundbreaking-research-project-with-doctor-leslie-mitchelson]
Country: United States
Website: http://www.ibogaineclinic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ibogaine By David DardashtiI Collaborates on Groundbreaking Research Project with Doctor Leslie Mitchelson here
News-ID: 3616477 • Views: …
More Releases from ABNewswire
Beyond Vending: Anno Robot's AI Baristas Deliver 'Master-Level' Coffee Art with …
The global food and beverage industry is at a tough point. It faces chronic labor shortages, soaring costs, and high consumer demand for convenience, quality, and 24/7 service. The old retail model cannot last. Service robotics is a new technology. It goes far beyond simple vending machines to deliver complex, high-quality services.
Market data shows this big change. The global food robotics market, which includes everything from factory floor automation to…
Potassium diformate and calcium formate were packed and shipped.
Calcium formate [https://www.aojinchem.com/calcium-formate-product/]is mainly used in the feed, construction, chemical, and agricultural industries. Specific applications are as follows:
1. Feed Industry: As an acidifier: Improves piglet appetite, reduces diarrhea rate, and increases daily weight gain and feed conversion rate. Adding 1%-1.5% can increase growth rate by over 12% and feed conversion rate by 4%.
2. Construction Industry: Concrete early-strength agent: Accelerates cement hardening and shortens setting time, especially suitable for winter construction.
3.…
How Prop Firm Models Are Adapting to ETFs
Prop trading firms are beginning to offer exchange traded funds (ETFs) within challenges and funded accounts, using exchange pricing instead of internal feeds. This is a shift towards more transparency in prop trading, because pricing and fills can be checked against public market data. The trading rules stay familiar with profit targets, drawdown limits, and daily loss caps designed to measure consistency, position sizing, and risk control under real market…
Liver Cancer Market Poised for Significant Growth from 2024 to 2034, Reports Del …
The Key Liver Cancer Companies in the market include - Eli Lilly, Merck, Genetech, GlaxoSmithKline, Bristol-Myers Squibb, and others.
DelveInsight's "Liver Cancer Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Liver Cancer, historical and forecasted epidemiology as well as the Liver Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Liver Cancer market…
More Releases for Ibogaine
Ibogaine by David Dardashti to Illuminate the Transformative Ibogaine Experience …
DENVER, CO - June 20, 2024 - Ibogaine by David Dardashti, a pioneer in holistic Ibogaine therapy, is proud to announce its prominent participation on Day 2 of the highly anticipated Psychedelic Conference 2025. David Dardashti and his team will offer individual descriptions of the unique Ibogaine experience, providing invaluable insights for each and every person at the conference seeking information regarding profound and lasting healing from addiction, trauma, and…
Ibogaine By David Dardashti is Pioneering Brain Wave Research in Ibogaine Treatm …
Renowned ibogaine expert David Dardashti is embarking on groundbreaking research measuring brain wave activity before and after ibogaine treatment. This study aims to shed light on ibogaine's impact on brain function and its potential to promote a more balanced and fulfilling life.
Brain waves are electrical impulses that are produced by the brain and can be measured using an electroencephalogram (EEG). There are four main types of brain waves: alpha, beta,…
Ibogaine By David Dardashti Initiates Ibogaine Data Storage on Google Cloud
Ibogaine By David Dardashti a leading psychedelic treatment center, today announced the commencement of ibogaine patient data storage and analysis on the Google Cloud platform. This initiative aims to leverage machine learning to enhance the precision and safety of ibogaine dosing based on past patient outcomes.
Ibogaine, a naturally occurring psychoactive substance, has shown promise in treating opioid addiction and other mental health conditions. However, its administration requires careful dosing due…
Ibogaine by David Dardashti Offers Proprietary Software to Accelerate Ibogaine R …
Ibogaine by David Dardashti, a renowned pioneer in ibogaine treatment and research, has recently made an exciting announcement regarding the availability of its proprietary software. This software is being offered to contribute to the donations made by Google co-founder towards ibogaine research specifically focused on traumatic brain injury.
This potential for collaboration between Ibogaine by David Dardashti and Google co-founder's donations signifies a significant step forward in the field of ibogaine…
Ibogaine By David Dardashti's Ibogaine Therapy Revolutionized by Questineers' SQ …
Ibogaine By David Dardashti, a leading innovator in the field of ibogaine therapy, today announced a groundbreaking advancement in the optimization of his ibogaine treatment software.
Dardashti's software has revolutionized the way patient data is analyzed by utilizing the power of SQL. Instead of manually sifting through mountains of data, healthcare providers can now simply ask the software specific questions to extract the information they need. This streamlined approach not only…
Ibogaine By David Dardashti Incorporates SQL into Ibogaine Software for Enhanced …
Ibogaine By David Dardashti, a leading provider of innovative solutions in the field of ibogaine therapy, today announced the integration of SQL (Structured Query Language) into its proprietary ibogaine software. This development marks a significant step forward in leveraging the power of data analysis to optimize the ibogaine algorithm for enhanced treatment outcomes
With the integration of SQL, Ibogaine By David Dardashti has significantly enhanced its ability to analyze a vast…
